If you want to learn more about the warning letter sent by the U.S. Food and Drug Administration and see how the FDA is still enforcing the status quo on CBD, keep on reading this article. Moreover, you’ll also learn where you can get approved for a safe and affordable CBD merchant account fast and easily.
FDA Warning Letter & CBD Merchant Account
The U.S. Food and Drug Administration is still taking action to regulate the legal issues associated with CBD. The administration has recently sent a warning letter to Alternative Laboratories or Alternative Labs. The letter shows that the company markets various functional beverages that contain enhanced coffees and cocoa drinks.
According to the letter, Alternative Labs has used the ingredient called DHMA in the beverages. As you may know, this is a synthetic drug that you can find in dietary supplements. It’s used for weight loss purposes, as well as for boosting athletic performance.
The FDA views supplements containing dimethylamylamine as illegal products. The use of dimethylamylamine has been associated with a number of reports of serious side effects causing harm to health.
According to Alternative Labs CEO Kevin Thomas, the inspection carried out by the FDA, which provided a basis for sending the warning letter didn’t reveal any serious issues concerning the company’s GMp compliance.
What about your marijuana business? Are you using reliable and low cost merchant services? This can be of no challenge if you work with a respectable high risk processor in your field. With a true payment processing specialist, you can enjoy the safest and cheapest CBD merchant account in the space.
Growing CBD Market & Its Regulation
According to Chuck Schumer, Senate Minority Leader, the FDA must provide guidance so that hemp-derived CBD can be marketed legally. Schumer adds that the administration’s rules concerning cannabidiol must ensure that CBD products meet strict quality control standards so that consumers can be well protected.
According to former FDA Commissioner Scott Gottlieb, the federal government should have its word in the process of state marijuana programs regulation. Gottlieb notes that CBD sales may need congressional action, otherwise years will be needed to develop rules.
To sum up, the warning letter by the FDA speaks of the fact that the administration is still enforcing the status quo on CBD.
Author Bio:Blair Thomas has been a music producer, bouncer, screenwriter and for over a decade has been the proud Co-Founder of eMerchantBroker, the highest rated high risk merchant account processor in the country that offers the safest and cheapest CBD merchant account in the space. He has climbed in the Himalayas, survived a hurricane, and lived on a gold mine in the Yukon. He currently calls Thailand his home with a lifetime collection of his favorite books.